Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
6000 participants
OBSERVATIONAL
2020-10-01
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Patient Registry for Radiation Oncology Techniques and Quality
NCT02368106
Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
NCT02457962
Xenon-enhanced Ventilation CT-guided Radiotherapy for Lung Cancer Treatment
NCT05134558
Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI
NCT05302817
Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy
NCT06159660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
breast
external beam photon therapy
Patients receive external beam photon therapy for different tumor locations (groups).
thorax
external beam photon therapy
Patients receive external beam photon therapy for different tumor locations (groups).
skin
external beam photon therapy
Patients receive external beam photon therapy for different tumor locations (groups).
abdomen
external beam photon therapy
Patients receive external beam photon therapy for different tumor locations (groups).
skull
external beam photon therapy
Patients receive external beam photon therapy for different tumor locations (groups).
head and neck
external beam photon therapy
Patients receive external beam photon therapy for different tumor locations (groups).
pelvis male
external beam photon therapy
Patients receive external beam photon therapy for different tumor locations (groups).
pelvis female
external beam photon therapy
Patients receive external beam photon therapy for different tumor locations (groups).
extremities
external beam photon therapy
Patients receive external beam photon therapy for different tumor locations (groups).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
external beam photon therapy
Patients receive external beam photon therapy for different tumor locations (groups).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gerd Heilemann
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gerd Heilemann, PhD
Role: primary
Andreas Renner, PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2184/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.